Reply to Jin et al. and to Sun et al

Athénaïs Boucly^{1

2

3}, Jason Weatherald⁴, Laurent Savale^{1

2

3}, Xavier Jaïs^{1

2

3}, David Montani^{1

2

3}, Marc Humbert^{1

2

3}, Olivier Sitbon^{1

2

3}

Affiliations

¹ Université Paris-Saclay Le Kremlin-Bicêtre, France.
² AP-HP, Hôpital Bicêtre Le Kremlin-Bicêtre, France.
³ INSERM UMR_S 999, Hôpital Marie Lannelongue Le Plessis-Robinson, France.
⁴ University of Calgary Calgary, Alberta, Canada.

PMID: 34672868
PMCID: PMC8865711
DOI: 10.1164/rccm.202107-1725LE

Comment

Reply to Jin et al. and to Sun et al

Athénaïs Boucly et al. Am J Respir Crit Care Med. 2021.

. 2021 Dec 15;204(12):1494-1495.

doi: 10.1164/rccm.202107-1725LE.

Authors

Athénaïs Boucly^{1

2

3}, Jason Weatherald⁴, Laurent Savale^{1

2

3}, Xavier Jaïs^{1

2

3}, David Montani^{1

2

3}, Marc Humbert^{1

2

3}, Olivier Sitbon^{1

2

3}

Affiliations

¹ Université Paris-Saclay Le Kremlin-Bicêtre, France.
² AP-HP, Hôpital Bicêtre Le Kremlin-Bicêtre, France.
³ INSERM UMR_S 999, Hôpital Marie Lannelongue Le Plessis-Robinson, France.
⁴ University of Calgary Calgary, Alberta, Canada.

PMID: 34672868
PMCID: PMC8865711
DOI: 10.1164/rccm.202107-1725LE

No abstract available

PubMed Disclaimer

Comment on

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O. Boucly A, et al. Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC. Am J Respir Crit Care Med. 2021. PMID: 34185620
Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
Jin Q, Guan L, Pan W, Zhou D. Jin Q, et al. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1491-1492. doi: 10.1164/rccm.202107-1622LE. Am J Respir Crit Care Med. 2021. PMID: 34672865 Free PMC article. No abstract available.
Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?
Sun X, Chen R, Yao X, Zheng Z, Wang M, Wang C, Cheng J. Sun X, et al. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1492-1493. doi: 10.1164/rccm.202108-1965LE. Am J Respir Crit Care Med. 2021. PMID: 34672866 Free PMC article. No abstract available.

References

1. Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, et al. Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension. Am J Respir Crit Care Med . 2021;204:842–854. - PubMed
1. Weatherald J, Reis A, Sitbon O, Humbert M. Pulmonary arterial hypertension registries: past, present and into the future. Eur Respir Rev . 2019;28:190128. - PMC - PubMed
1. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol . 2013;62(25)(Suppl):D51–D59. - PubMed
1. Humbert M, Barst RJ, Robbins IM, Channick RN, Galiè N, Boonstra A, et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J . 2004;24:353–359. - PubMed
1. Galiè N, Barberà JA, Frost AE, Ghofrani H-A, Hoeper MM, McLaughlin VV, et al. AMBITION Investigators. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med . 2015;373:834–844. - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to Jin et al. and to Sun et al

Affiliations

Reply to Jin et al. and to Sun et al

Authors

Affiliations

Comment on

References

Publication types

LinkOut - more resources

Full Text Sources